BioSpace News Archive

Transgene (Paris:TNG) (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies against cancers and infectious diseases announces the signing of a collaborative research, option and exclusive license agreement with AstraZeneca to co-develop five armed oncolytic vaccinia virus candidates.

NantHealth, Inc. announced that it will report financial results for its 2019 first quarter on Thursday, May 9, 2019, after market close.

Ortoma and the Board of Directors have engaged MedWorld Advisors as M&A advisor to assist the company and the Board with management, evaluations, and negotiations in connection with any M&A transaction.

Nolato AB will publish its report for the three first months 2019 on Wednesday 8 May 2019 at 1.30 p.m. CET.

Total net revenues of SEK 174.3 million (139.7), up 24.8 percent

SigNature® T Traceability System to be Installed in Egypt to Tag Two Cotton Varietals

Over $200 Million Investment in Massachusetts Creates Hundreds of Local Manufacturing Jobs and a Launchpad for New Product Innovation

Quarterly net revenues of $73.3 million, representing 41 percent growth versus the first quarter 2018 and 5 percent growth versus the fourth quarter 2018

INBRIJA™ (levodopa inhalation powder) commercially available on February 28; first and only FDA-approved inhaled levodopa for intermittent treatment of OFF episodes in people with Parkinson’s taking carbidopa/levodopa

Net sales decreased 10 percent to $10.8 billion, in-line with the division’s modeling guidance. This compares to net sales of $12.0 billion in the year-ago period.